Sunhawk Vision Biotech, Inc.
- Biotech or pharma, therapeutic R&D
Sunhawk Vision Biotech (used to call Dreamhawk) is a clinic-stage company focused on RNA therapy for ocular diseases via eye drops instillation. The product pipelines include myopia, dry eye disease (DED), corneal erosion etc. Both phase-2 trials for DED and corneal erosion have shown significant results (in both statistical and clinical significance) in improving both signs and symptoms of DED and corneal repair. The company is currently conducting a phase-2 trial for myopia control in children and plan to submit phase-3 IND for DED by the end of 2025.
Address
TaipeiNA
Taiwan
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}